The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is BPC 157 Legal? Understanding Its Status and Implications FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Compounded "semaglutide" is not FDA approved semaglutide.com BPC 157: Experimental Peptide Creates Risk for Athletes